Annual Long Term Debt
$4.40 M
-$1.45 M-24.80%
December 31, 2023
Summary
- As of February 12, 2025, ABEO annual long term debt is $4.40 million, with the most recent change of -$1.45 million (-24.80%) on December 31, 2023.
- During the last 3 years, ABEO annual long term debt has fallen by -$2.29 million (-34.18%).
- ABEO annual long term debt is now -69.07% below its all-time high of $14.23 million, reached on December 31, 2002.
Performance
ABEO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$17.61 M
-$1.54 M-8.06%
September 30, 2024
Summary
- As of February 12, 2025, ABEO quarterly long term debt is $17.61 million, with the most recent change of -$1.54 million (-8.06%) on September 30, 2024.
- Over the past year, ABEO quarterly long term debt has increased by +$13.21 million (+300.00%).
- ABEO quarterly long term debt is now -20.42% below its all-time high of $22.13 million, reached on March 31, 2024.
Performance
ABEO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ABEO Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.8% | +300.0% |
| 3 y3 years | -34.2% | +296.4% |
| 5 y5 years | +100.0% | +171.6% |
ABEO Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.8% | at low | -20.4% | +335.5% |
| 5 y | 5-year | -41.8% | at low | -20.4% | +335.5% |
| alltime | all time | -69.1% | -100.0% | -20.4% | -100.0% |
Abeona Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.61 M(-8.1%) |
| Jun 2024 | - | $19.15 M(-13.4%) |
| Mar 2024 | - | $22.13 M(+402.6%) |
| Dec 2023 | $4.40 M(-24.8%) | $4.40 M(+8.9%) |
| Sep 2023 | - | $4.04 M(-7.6%) |
| Jun 2023 | - | $4.38 M(-20.8%) |
| Mar 2023 | - | $5.53 M(-5.5%) |
| Dec 2022 | $5.85 M(-22.6%) | $5.85 M(-9.7%) |
| Sep 2022 | - | $6.48 M(-3.8%) |
| Jun 2022 | - | $6.74 M(-7.4%) |
| Mar 2022 | - | $7.27 M(-3.8%) |
| Dec 2021 | $7.56 M(+13.0%) | $7.56 M(+70.2%) |
| Sep 2021 | - | $4.44 M(-5.9%) |
| Jun 2021 | - | $4.72 M(-23.9%) |
| Mar 2021 | - | $6.20 M(-7.3%) |
| Dec 2020 | $6.69 M(+7.0%) | $6.69 M(+21.2%) |
| Sep 2020 | - | $5.52 M(-4.4%) |
| Jun 2020 | - | $5.77 M(-4.1%) |
| Mar 2020 | - | $6.01 M(-3.8%) |
| Dec 2019 | $6.25 M(>+9900.0%) | $6.25 M(-3.6%) |
| Sep 2019 | - | $6.48 M(-3.4%) |
| Jun 2019 | - | $6.71 M(-3.2%) |
| Mar 2019 | - | $6.93 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2011 | - | $2.75 M(-50.0%) |
| Jun 2010 | - | $5.50 M(0.0%) |
| Mar 2010 | - | $5.50 M(0.0%) |
| Dec 2009 | $5.50 M(0.0%) | $5.50 M(0.0%) |
| Sep 2009 | - | $5.50 M(0.0%) |
| Jun 2009 | - | $5.50 M(0.0%) |
| Mar 2009 | - | $5.50 M(0.0%) |
| Dec 2008 | $5.50 M | $5.50 M(0.0%) |
| Sep 2008 | - | $5.50 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $5.50 M(0.0%) |
| Mar 2008 | - | $5.50 M(0.0%) |
| Dec 2007 | $5.50 M(0.0%) | $5.50 M(0.0%) |
| Sep 2007 | - | $5.50 M(0.0%) |
| Jun 2007 | - | $5.50 M(0.0%) |
| Mar 2007 | - | $5.50 M(0.0%) |
| Dec 2006 | $5.50 M(-28.0%) | $5.50 M(0.0%) |
| Sep 2006 | - | $5.50 M(0.0%) |
| Jun 2006 | - | $5.50 M(-31.2%) |
| Mar 2006 | - | $7.99 M(+4.7%) |
| Dec 2005 | $7.64 M(+36.3%) | $7.64 M(-20.1%) |
| Sep 2005 | - | $9.55 M(+70.2%) |
| Jun 2005 | - | $5.61 M(-0.7%) |
| Mar 2005 | - | $5.65 M(+0.9%) |
| Dec 2004 | $5.60 M(-60.0%) | $5.60 M(-1.8%) |
| Sep 2004 | - | $5.70 M(-58.6%) |
| Jun 2004 | - | $13.78 M(-0.8%) |
| Mar 2004 | - | $13.88 M(-1.0%) |
| Dec 2003 | $14.02 M(-1.5%) | $14.02 M(+0.2%) |
| Sep 2003 | - | $13.99 M(-0.1%) |
| Jun 2003 | - | $14.01 M(-0.1%) |
| Mar 2003 | - | $14.03 M(-1.4%) |
| Dec 2002 | $14.23 M(+2940.6%) | $14.23 M(+0.1%) |
| Sep 2002 | - | $14.22 M(+1888.3%) |
| Jun 2002 | - | $715.00 K(-94.9%) |
| Mar 2002 | - | $13.97 M(+2885.0%) |
| Dec 2001 | $468.00 K(+229.6%) | $468.00 K(-96.7%) |
| Sep 2001 | - | $14.03 M(+3.7%) |
| Jun 2001 | - | $13.53 M(0.0%) |
| Sep 2000 | - | $13.53 M(>+9900.0%) |
| Jun 1999 | - | $3000.00(-62.5%) |
| Mar 1999 | - | $8000.00 |
| Dec 1997 | $142.00 K(-26.4%) | - |
| Dec 1996 | $193.00 K | - |
FAQ
- What is Abeona Therapeutics annual long term debt?
- What is the all time high annual long term debt for Abeona Therapeutics?
- What is Abeona Therapeutics annual long term debt year-on-year change?
- What is Abeona Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly long term debt year-on-year change?
What is Abeona Therapeutics annual long term debt?
The current annual long term debt of ABEO is $4.40 M
What is the all time high annual long term debt for Abeona Therapeutics?
Abeona Therapeutics all-time high annual long term debt is $14.23 M
What is Abeona Therapeutics annual long term debt year-on-year change?
Over the past year, ABEO annual long term debt has changed by -$1.45 M (-24.80%)
What is Abeona Therapeutics quarterly long term debt?
The current quarterly long term debt of ABEO is $17.61 M
What is the all time high quarterly long term debt for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly long term debt is $22.13 M
What is Abeona Therapeutics quarterly long term debt year-on-year change?
Over the past year, ABEO quarterly long term debt has changed by +$13.21 M (+300.00%)